These results support that Recilisib could partially reverse the anti-proliferation effect of TAX on DU145 and PC3 cells, demonstrating that TAX inhibits the proliferation of androgen-independent PCa cells via weakening PI3K/AKT signaling pathway and reducing the expression of FGFR2. Here, AKT1 is linked to posterior cortical atrophy.